Page last updated: 2024-10-29

isradipine and Bleeding

isradipine has been researched along with Bleeding in 1 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Research Excerpts

ExcerptRelevanceReference
" We identified 43 subjects from general practice with uncomplicated mild to moderate hypertension to compare the effects of the calcium antagonist isradipine with that of the beta-blocker atenolol on platelet function, plasma beta-thromboglobulin levels, fibrinolysis, and serum lipids in a randomised double-blind parallel group study."5.08Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects. ( Carney, S; Gillies, A; Mason, A; McPherson, J; Smith, A; Taylor, M, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, A1
McPherson, J1
Taylor, M1
Mason, A1
Carney, S1
Gillies, A1

Trials

1 trial available for isradipine and Bleeding

ArticleYear
Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects.
    Journal of human hypertension, 1997, Volume: 11, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Atenolol; beta-Thromboglobulin; Blood Platelets; Blood Pressure;

1997